Наша группа организует более 3000 глобальных конференций Ежегодные мероприятия в США, Европе и США. Азия при поддержке еще 1000 научных обществ и публикует более 700 Открытого доступа Журналы, в которых представлены более 50 000 выдающихся деятелей, авторитетных учёных, входящих в редколлегии.
Журналы открытого доступа набирают больше читателей и цитируемости
700 журналов и 15 000 000 читателей Каждый журнал получает более 25 000 читателей
Syed Nouman Mohsin
Aim: To assess the existing first line triple therapy in patients for possible resistance.
Materials and Methods: Retrospective assessment of all patients who had their Helicobacter pylori positive with biopsies taken for various reasons during gastroscopy followed by confirmation of eradication with 13C-urea test over a time period of one year.
Results: Out of 1548 gastroscopies where CLO (Campylobacter-like Organism test) was taken that were done over a time period of 1 year, 242 (15.63%) patients had their helicobacter-like organism test positive. Triple regime was prescribed for eradication in all of them and retesting with 13C urea breath test after six weeks reveal successful eradication in 192 (79.3%) and failed eradication in only 50 (20.7%) of the patients.
Conclusion: The first line regime for the eradication of Helicobacter pylori used in our hospital is efficient for the eradication and there is no any amendment that has to be made in the current regime.